首页> 外文学位 >Mitogen-activated protein kinases mediate angiotensin II-induced upregulation of AT1 receptors in the brain of heart failure rats .
【24h】

Mitogen-activated protein kinases mediate angiotensin II-induced upregulation of AT1 receptors in the brain of heart failure rats .

机译:丝裂原激活的蛋白激酶介导血管紧张素II诱导的心力衰竭大鼠脑中AT1受体的上调。

获取原文
获取原文并翻译 | 示例

摘要

Chronic heart failure (HF) is characterized by activation of the renin-angiotensin system (RAS) and increased sympathetic outflow. The brain RAS is upregulated and contributes to the progression of HF. I examined the mechanisms responsible for upregulation of the brain angiotensin type I receptor (AT1-R), the component of brain RAS which mediates the effects of angiotensin II (ANG II). Using molecular biology and immunohistochemical techniques, AT1-R expression was detected in the paraventricular nucleus of hypothalamus (PVN) and the subfornical organ (SFO), two key brain regions that regulate sympathetic drive, blood pressure and body fluid homeostasis. The role of ANG II-stimulated mitogen-activated protein kinases (MAPK) in the AT1-R upregulation in HF was investigated by selectively blocking distinct signaling molecules in this pathway. In addition, the effects of inhibiting MAPK activity on cardiovascular responses and sympathetic drive in HF were examined.; Experimental data were obtained from rats with HF induced by myocardial infarction and normal rats chronically infused with ANGII. The levels of AT 1-R protein, AT1-R mRNA and AT1-R-like immunoreactivity were all significantly increased in the PVN and SFO in HF rats and ANG II-infused rats, compared with control animals. The levels of phosphorylated MAPK p44/42, p38 and JNK in the PVN and SFO were similarly elevated. Chronic intracerebroventricular administration of an AT1-R antagonist, two p44/42 MAPK inhibitors and a c-Jun N-terminal kinase (JNK) inhibitor all significantly reduced AT 1-R expression in the PVN and SFO in HF rats and ANG II-infused rats. Chronic infusion of the p38 MAPK inhibitor did not affect AT1-R expression. Brief intracerebroventricular infusions of the p44/42 MAPK inhibitors lowered arterial pressure, heart rate and renal sympathetic nerve activity in HF rats, but had no effect on lumbar sympathetic nerve activity.; The findings demonstrate that increased ANG II, in HF rats and in normal rats, upregulates its own AT1-R in cardiovascular and autonomic regions of the brain, and that p44/42 MAPK and JNK intracellular signaling pathways play a key role in this process. Activated p44/42 MAPK also appears to contribute to the sustained increase in renal sympathetic excitation in rats with HF.
机译:慢性心力衰竭(HF)的特征在于激活肾素-血管紧张素系统(RAS)和增加交感神经。大脑RAS上调并有助于HF的进展。我检查了负责上调脑I型血管紧张素受体(AT1-R)的机制,这是介导血管紧张素II(ANG II)作用的大脑RAS的组成部分。使用分子生物学和免疫组化技术,在下丘脑室旁核(PVN)和子下器官(SFO)(调节交感神经,血压和体液稳态的两个关键大脑区域)中检测到AT1-R表达。通过选择性阻断该途径中的不同信号分子,研究了ANG II刺激的丝裂原活化蛋白激酶(MAPK)在HF的AT1-R上调中的作用。此外,还研究了抑制MAPK活性对心衰患者心血管反应和交感神经驱动的影响。实验数据来自于心肌梗塞诱发的HF大鼠和慢性输注ANGII的正常大鼠。与对照组相比,HF大鼠和ANG II输注大鼠的PVN和SFO中AT 1-R蛋白,AT1-R mRNA和AT1-R样免疫反应性水平均显着增加。 PVN和SFO中磷酸化的MAPK p44 / 42,p38和JNK的水平也同样升高。长期脑室内给予AT1-R拮抗剂,两种p44 / 42 MAPK抑制剂和c-Jun N末端激酶(JNK)抑制剂均可显着降低HF大鼠和ANGII注入的PVN和SFO中AT 1-R的表达大鼠。长期输注p38 MAPK抑制剂不会影响AT1-R的表达。短暂脑室内注入p44 / 42 MAPK抑制剂可降低HF大鼠的动脉压,心率和肾交感神经活性,但对腰交感神经活性无影响。这些发现表明,在HF大鼠和正常大鼠中,ANG II的升高会在大脑的心血管和自主神经区域中上调其自身的AT1-R,并且p44 / 42 MAPK和JNK细胞内信号通路在该过程中起关键作用。激活的p44 / 42 MAPK也似乎有助于HF大鼠肾脏交感神经兴奋的持续增加。

著录项

  • 作者

    Wei, Shunguang.;

  • 作者单位

    The University of Iowa.;

  • 授予单位 The University of Iowa.;
  • 学科 Biology Neuroscience.; Biology Physiology.
  • 学位 Ph.D.
  • 年度 2007
  • 页码 168 p.
  • 总页数 168
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 神经科学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号